Study finds warmer temperatures increase migraines by 6% per 10-degree F rise; Fremanezumab treatment reduces association.
A study by the University of Cincinnati, Mount Sinai, Errex Inc., and Teva Pharmaceuticals found warmer temperatures increase migraine occurrences by 6% for every 10-degree Fahrenheit increase. During Fremanezumab treatment, the association between temperature and headaches disappeared. The drug, which blocks a protein responsible for pain transmission, has the potential to help those with weather-triggered migraines, if confirmed in future studies.
June 15, 2024
3 Articles